ORIGINAL ARTICLE |
|
Year : 2020 | Volume
: 32
| Issue : 2 | Page : 159-163 |
|
The short-term effects of intravitreal injection of bevacizumab on the plasma levels of vascular endothelial growth factor, insulin-like growth factor-1, and growth parameters in infants with retinopathy of prematurity
Ahad Sedaghat1, Parya Abdolalizadeh1, Mohammad Mehdi Parvaresh1, Sajad Ghorbanizadeh1, Parisa Mohagheghi2, Kaveh Abri Aghdam1
1 Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran 2 Department of Pediatrics, Division of Neonatology, Newborn Intensive Care Unit, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
Correspondence Address:
Kaveh Abri Aghdam Department of Ophthalmology, Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Sattarkhan-Niayesh Street, Tehran 14456-13131 Iran
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JOCO.JOCO_78_20
|
|
Purpose: To determine the changes in serum levels of free vascular endothelial growth factor (VEGF), insulin-like growth factor-1 (IGF-1), and growth parameters in infants with retinopathy of prematurity (ROP) who received intravitreal injection of the bevacizumab (IVB).
Methods: A prospective interventional case series study, including 10 infants with Type 1 ROP was conducted. Using the enzyme-linked immunosorbent assay, serum levels of VEGF and IGF-1 were measured before, 1 month and 2 months after treatment with IVB in both eyes. Growth parameters, including weight, length, and head circumference and their Fenton's z-score, were also measured.
Results: Serum VEGF levels were suppressed 1 month after IVB (P = 0.007) and then increased between 1 and 2 months (P = 0.064). Z-scores of all growth parameters except weight z-score decreased in the 1st and 2nd months.
Conclusion: Serum VEGF levels showed a transient reduction after IVB which lasted at least 2 months. Growth velocity of premature infants may be affected by anti-VEGF therapy and should be followed with particular attention.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|